 This randomized, controlled, 28-day parallel study will include one screening Visit Visit 1, Day -14, two baseline visits Visits 2 and 3; Days -3 and 0 and three test visits Visits 4, 5, and 6; Days 14, 25, and 28, and two contact reminders Days 7 and 21. 